|
CEP170 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00020003390711E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.40590000000207E-06 |
| Normal-vs-Stage2 |
3.423700E-04 |
| Normal-vs-Stage3 |
4.30009999996539E-06 |
| Normal-vs-Stage4 |
2.656300E-02 |
| Stage1-vs-Stage2 |
5.874000E-02 |
| Stage1-vs-Stage3 |
1.478110E-02 |
| Stage1-vs-Stage4 |
1.549240E-01 |
| Stage2-vs-Stage3 |
5.513800E-01 |
| Stage2-vs-Stage4 |
4.253600E-01 |
| Stage3-vs-Stage4 |
6.106600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1006999473272E-09 |
| Normal-vs-AfricanAmerican |
4.89479999998821E-06 |
| Normal-vs-Asian |
2.865800E-02 |
| Caucasian-vs-AfricanAmerican |
8.103400E-01 |
| Caucasian-vs-Asian |
5.079200E-01 |
| AfricanAmerican-vs-Asian |
5.850400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.11219999771239E-08 |
| Normal-vs-Female |
5.03439956389684E-10 |
| Male-vs-Female |
1.206440E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.753900E-04 |
| Normal-vs-Extreme_Weight |
1.60950000005489E-06 |
| Normal-vs-Obese |
4.32160000007897E-08 |
| Normal-vs-Extreme_Obese |
9.656100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.145600E-01 |
| Normal_Weight-vs-Obese |
3.868600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.289000E-01 |
| Extreme_Weight-vs-Obese |
4.886100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.538400E-01 |
| Obese-vs-Extreme_Obese |
2.155600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.449400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.78620468310942E-11 |
| Normal-vs-Age(61-80Yrs) |
1.30580000001768E-06 |
| Normal-vs-Age(81-100Yrs) |
6.186200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.103200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.162300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.003510E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.901900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.703600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.876600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.84610002021913E-09 |
| Normal-VS-Type2 PRCC |
1.755730E-04 |
| Normal-VS-KIRP CIMP |
8.606500E-04 |
| Normal-VS-Unclassified PRCC |
1.98539999995972E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.656600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.955770E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.811800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.124100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.435600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.341210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.98000000000743E-05 |
| Normal-vs-N1 |
1.89272999999712E-05 |
| Normal-vs-N2 |
4.436500E-02 |
| N0-vs-N1 |
1.218890E-03 |
| N0-vs-N2 |
2.553500E-04 |
| N1-vs-N2 |
8.879800E-01 |
|
|
